With the advances of management, patients with Acute Myocardial Infarction (AMI) or Acute Coronary Syndrome (ACS), by Percutaneous coronary Intervention (PCI) by using bare metal stent (BMS) reduces the acute closure or late restenosis compared with balloon angioplasty alone, has already established. 1-2 With the property of site specific antiproliferating drug delivery system by drug eluting stent (DES) reduces the clinical and angiographic restenosis by <10% by inhibiting neointimal hyperplasia. [3] [4] Several studies have shown increase in procedural success and survival out come with the reduction of MACE and late luminal loss and restenosis by Sirolimus eluting stent than bare metal stent. [5] [6] Vessel size, specially small vessel with increase in tortuosity, diabetes with complex lesion, lengthy plaque are major contributory factors in stent restenosis. In the Drug stent era, successful PCI in CTO lesions is really a great challenge for interventionist. In this present study, we have evaluated primary end point of 30 days survival out come after successful PCI in patients with CTO lesion.
Methods:
Definition: Chronic Total occlusion(CTO) lesion was defined as an angiographically, no antegrade filling of distal vessel other than via collaterals. All patients included had a native vessel occlusion estimated to be of at least one month's duration 7 based on either a history of sudden chest pain or a previous myocardial infarction in the same target territory, the evidence of ischaemia related to target vessel (signs of ischaemia during an abnormal TMT (ST depression>1.0mm horizontal or down sloping or up sloping ST depression >2.0mm or signs of ongoing angina with the ECG changes on the target territory). However, temporal criteria to define CTO lesion was ranging from >2weeks to >3 months. In general lesions with >3 months were considered as Chronic according to the AHA/ACC lesion classification. The estimated length of the occlusion was measured from the point of the total occlusion to the most proximal part of the distal vessel which was visualized by collaterals filled by contrast. 5, 8 Consents were taken from all these patients.
Patient Population:
Patients were randomized from the all PCI procedures at our centers as per definition of CTO lesions were included in this study. Study period was from January 2007 to June 2009. Total 56 CTO was attempted and 6 patients were excluded from the study due to guide wire crossing failure. Total 5 patients had DVD, for which PCI was done in addition to the targeted CTO lesion.
PCI either were done with BMS or DES. DES included Cypher (Cordis, USA) and TAXUS (Boston Scientific, USA). The BMS included MultilinkVision, Zeta (Guidant, USA) and micro-Driver (Medtronic, USA) and Genous (Orbus, Netherlands). Coronary angioplasty was performed according to standard rules. Neither ablative techniques (rotablator, directional atherectomy) nor cutting balloon were used. Predilatation was optional before stent implantation with a shorter balloon to avoid geographic miss. A successful procedures was defined as TIMI-3 antegrade flow, and <20% residual stenosis in two orthogonal views.
Post-deployment dilation was performed at high inflation pressure in all patients.
Drug Therapy:
All the patients received Aspirin 300 mg/day and Clopidegrol as a loading dose 300 mg prior to PCI and recommended to continue for at least 9 months and received atorvastatin along with standard Medical management for CAD. During the procedure, an intravenous heparin bolus (100IU/ Kg) and GP IIb/IIIa receptor blocker Integrilin were administered as required. The use of GP IIb/IIIa Receptor blocker was recommended as per protocol. Quantitative angiographic measurements of the target lesion were obtained in order to deploy correct size stent. In the event of chest pain, postprocedural ECG and CPK were measured and compared with the baseline. Check angio were taken, whenever indicated.
Statistical analysis:
All data were expressed as mean ± SD (Quantitative variables) and percentile of distribution (categorical). Body mass Index (BMI) were calculated as body weight in kg divided by height in sq meter (kg/m 2 ).
Results:
PCI were performed in total 50 patients (Male 41, Female 9) with CTO lesion. Female are older than male (male 53.3 ± 9.9 vs female: 64.4 ± 11.9) and more obese (BMI in male: 25.5 ± 2.8 vs female 26.4 ± 3.2). Both systolic and Diastolic BP were higher in female than male (Male: Female 136 ± 18.2 vs148.2 ± 33.2 : 79.8 ±11.9 vs 85 ±11.2). Average number of CAD risk factors were higher in male than female (2.3 ± 1.1: 2.1 ± 0.8). 
Discussion:
By definition, a CTO lesion, is a lesion of more than 3 months duration with thrombolysis in myocardial infarction (TIMI) grade 0 or I-distal flow. 9 In the absence of serial angiogram, clinical timing of Acute MI or angina with ECG changes consistent with the location of occlusion is helpful to estimate the duration of occlusion.
Intervention in CTO lesion is a major challenge for the cardiologist practicing PCI. Success rates of PCI in CTOs have steadily increased over the last 15 yrs because of greater operator experiences, improvements in equipments and procedural techniques. [10] [11] Length of occlusion, duration of occlusion, presence of tapered entry configuration, bridging collaterals and calcification are also important predictors of procedural success. [12] [13] New concept for CTO recanalization using controlled Antegrade and Retrograde Subintimal Tracking (CART) is a favorable strategy for invasive cardiologist. This has shown a feasible, safe and higher success rate, 14 although, procedural success of PCI of patients with CTO lesion was 55-90%. [15] [16] Most interventional cardiologist has their own set standard within the already framed guidelines by ACC/AHA/ESC. Stone et al 14 has recommended that in general, when CTO represented by significant lesion in the coronary tree, PCI is warranted in 3 condition: 1) occluded vessel is responsible for the clinical symptoms, 2) Myocardial territory supplied by the occluded vessel, and 3) the likelihood of success is moderate to high (>60%) with anticipated major complications like death to be <1% and myocardial infarction to be <5%.
Attempts at CTO revascularization represents of 8-15% of all PCI. [17] [18] [19] It improves anginal symptoms, exercise tolerance and LV function 20 In addition, it lessens the incidences of MACE including cardiac mortality. 9, [21] [22] The most common mode for PCI failure in CTOs, is the inability to successful passage of a guidewire into the true lumen of the distal vessel. [23] [24] Kinoshita et al has demonstrated that failure to cross guidewire(63%), long intimal dissection with creation of false lumen (24%) , dye extravasations, failure to cross the lesion with balloon or dilate adequately (2%) and thrombosis(1.2%) are the common problems encountered in CTO intervention.
In our present study, we had limitations of singlecentered trial. As most of our patients are not being covered by insurance and noncompliance with follow-up in OPD is difficult. Therefore, we had to limit our study of PCI on these patients up to 30 days after the procedures.
In our present study we found that female are more obese and developed CAD in more advance age than male patients. Admission BP was higher in female either due to obesity or from noncompliance to their current medication. We also found that average number of CAD risk factors were higher in male than female, although male are having one more exclusive CAD risk factors as being smoker. Among the CAD risk factors dyslipidemia contributed an important role in the development of atherosclerotic CAD followed by HTN, DM and positive FH and smoking (male patient). Incidences of CTO lesion were higher in LAD followed by RCA and LCX of the studied population was consistent with the results of Holmes et al. 25 Our results are consistent with others studies which showed, that the above mentioned risk factors are the major contributing factor in the development of CAD, specially CTO lesion. Interestingly, we found that that the CTO lesions were more common in patients with unstable angina followed by Ant MI, Inferior MI and NSTEMI.
Patients were followed-up at Cardiac outpatient department. None of them has any complaint of new onset of anginal chest pain, any new changes in repeat ECG and echocardiography. In the present study, none of the patient needed repeat procedures or had MACE like MI, Death, acute Stent thrombosis during in-hospital and 30 days after the procedure.
In the future, we would like to focus on long term survival outcome studies of these patients for up to 6-12 months, if possible angiographically. Effective reduction of in-stent restenosis by Sirolimus-eluting or Paclitaxel-eluting stents versus bare metal stent need to be clarified.
In our present study, none of the patient had procedural complications. We therefore, within limited resources (unavailability of special CTO wires and IVUS), were able to demonstrate that PCI in the CTOs increases procedural success and 30day survival in our population.
Conclusion:
CTO lesion is one of most the complex and critical type of CAD lesion. This usually carries a lot of procedural risk during or after successful intervention. For this reason, they, need to be followed up at regular interval to evaluate and see its success as complications are more common. Our future focus, is to study the long-term survival outcome and restenosis rate of CTO lesion either by BMS or DES in the context of Bangladesh. This needs to be clarified more by retrospective as well as by comparative study in a larger population.
